Latest filing published 22 Dec 2023 for Genscript Biotech Corporation, €6,448.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Pan Yuexin: trading record in brief
Pan Yuexin appears in our data through filings on Genscript Biotech Corporation shares, published by HKEX. We count 7 filings; the first trade dates from 29 November 2018 and the latest from 20 December 2023.
Both buying and selling appear: 4 purchases, against 2 sales worth €887k. The amount is not disclosed for 4 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2023: 2 purchases and 2 sales on the market.
Most recently, on 22 December 2023, the filings show an open-market sale worth €6,448 in Genscript Biotech Corporation. The last purchase on record was published on 1 December 2023, which is 1,074 days ago. Filings reach the HKEX feed a median of 4 days after the trade. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Pan Yuexin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,731 shares@ HK$20.22380.4% of flowShareXHKGHKEX:DA20231222E00281
- 34,409 sharesShareXHKGHKEX:DA20231201E00163Canonical exit: 26 Feb 2024 (T+90)
- 345,376 shares@ HK$21.0256.2% of flowShareXHKGHKEX:DA20231017E00327
- 400,000 shares@ HK$14.0443.4% of flowShareXHKGHKEX:DA20231017E00326
- 14,929 sharesShareXHKGHKEX:DA20230126E00491Canonical exit: 18 Apr 2023 (T+90)
- 60,000 sharesShareXHKGHKEX:DA20200903E00410Canonical exit: 30 Nov 2020 (T+90)
- 400,000 sharesShareXHKGHKEX:DA20190127E00057Canonical exit: 27 Feb 2019 (T+90)
7 of 7 declarations
